ARDS

Aridis Pharmaceuticals Inc
0.6701
-0.0012 (-0.18%)

Aridis Pharmaceuticals Inc. (ARDS) Fundamentals

Aridis Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is engaged in the discovery and development of targeted immunotherapy using fully human monoclonal antibodies, or mAbs, to treat life-threatening infections.
SHARE INFORMATION
Market Cap$ 17,436,032
Shares Outstanding25,973,532
Float24,526,947
Percent Float94.43%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 0
Latest Fiscal EPS$ -3.65
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions33
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months91,053
Institutional Holdings Percent15.0%
Institutional Sold Previous 3 Months38,552
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months122,000
Insider Holdings Percent5.6
Insider Sold Previous 3 Months-
Insider Shares Owned1,446,585
TRADING INFO
52 Week High$ 2.94
52 Week Low$ 0.57
52 Week High Change$ -66.60
21 Day Moving Average$ 1.1077
21 Day Extended Moving Average$ 0.970436
50 Day Moving Average$ 1.0387
50 Day Extended Moving Average$ 1.0374
200 Day Moving Average$ 1.2285
200 Day Extended Moving Average$ 1.4056
10 Day Average Volume4,790,914
20 Day Average Volume2,457,762
30 Day Average Volume1,704,282
50 Day Average Volume1,067,594
Alpha-0.032876
Beta1.0462
Standard Deviation0.269511
R20.048460
7 Day Price Change$ -0.1287
7 Day Percent Change-16.09%
21 Day Price Change$ -0.587
21 Day Percent Change-46.65%
30 Day Price Change$ -0.5087
30 Day Percent Change-43.11%
Month to Date Price Change$ 0.0013
Month to Date Percent Change0.19%
Quarter to Date Price Change$ -0.5087
Quarter to Date Percent Change-43.11%
180 Day Price Change$ -1.51
180 Day Percent Change-69.21%
200 Day Price Change$ -0.4287
200 Day Percent Change-38.97%
Year to Date Price Change$ -0.5087
Year to Date Percent Change-43.11%

Aridis Pharmaceuticals Inc. (ARDS) Key Ratios

PROFITABILITY
EBIT Margin-3,094.0%
EBITDA Margin-3,058.5%
Pre-Tax Profit Margin-2,313.4%
Profit Margin Count0.0%
Gross Margin0.0%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 0
Revenue Per Share$ 0.00
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book-0.50
Total Debt To Equity0.00
Int Coverage0.00
Current Ratio0.20
Leverage Ratio-0.60
Quick Ratio0.10
Long Term Debt To Capital0.00
VALUATION MEASURES
PE Ratio-0.40
Enterprise Value$ 30,316,733
Price to Sales0.00
Price to Free Cash-0.90
PE High Last 5 Years0.00
Price To Book0.00
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book-0.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.00
Invoice Turnover0.00
Assets Turnover0.00
Return Assets-171.67
Return on Equity164.06
Return on Capital-770.63

Aridis Pharmaceuticals Inc. (ARDS) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorMayer Hoffman McCann P.C.
CEOVu Truong
Emplyoees34
Last AuditUE
CIK0001614067
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address983 University Avenue
Building B
Los Gatos, CA 95032
Websitehttps://www.aridispharma.com
Facsimile+1 408 356-9548
Telephone+1 408 385-1742
EmailSherl@aridispharma.com


Your Recent History
NASDAQ
ARDS
Aridis Pha..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.